Detalles de la búsqueda
1.
Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted RSV Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With a Seasonal Quadrivalent Influenza Vaccine in Older Adults: Results of a Phase 3, Open-Label, Randomized Controlled Trial.
Clin Infect Dis;
2024 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38189778
2.
Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial.
Lancet;
395(10234): 1434-1443, 2020 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32197107
Resultados
1 -
2
de 2
1
Próxima >
>>